Business
Alzheimer’s drug aducanumab faces major setback as US authorities consider whether to approve it – ABC News
A drug company is seeking to get an experimental Alzheimer’s drug approved by the FDA. If they succeed it would be a major breakthrough. But just how convincing…
For almost two decades, the field of Alzheimer’s research has been dogged by treatment failures, leaving patients and their families desperate for hope.
But the makers of a new experimental drug, currently under consideration for regulatory approval by the US Food and Drug Administration (FDA), want to change that.
If Aducanumab, developed by pharmaceutical company Biogen, is approved by the FDA, it would be the first Alzheimer’s drug to be greenlit in 20 years.
Last week, Biogen’s stock price soared…
-
Noosa News21 hours agoRallies under way as nationwide support for Palestine surges
-
General21 hours agoTens of thousands protest in nationwide action against war in Gaza
-
General24 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats
-
General19 hours agoThousands flood cities demanding action on Palestine